Tripuraneni Radhika 4
4 · Terns Pharmaceuticals, Inc. · Filed Jul 28, 2022
Insider Transaction Report
Form 4
Tripuraneni Radhika
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-26+64,000→ 64,000 totalExercise: $2.13Exp: 2032-07-25→ Common Stock (64,000 underlying)
Footnotes (1)
- [F1]1/3rd of the shares subject to the option vest on the first anniversary measured from July 26, 2022 (the "Vesting Commencement Date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date.